Introduction	O

Yeast	O
infections	O
cause	O
significant	O
mortality	O
in	O
critically	O
ill	O
and	O
immunocompromised	O
patients	O
.	O

In	O
particular	O
,	O
Candida	O
species	O
are	O
the	O
4th	O
most	O
common	O
cause	O
of	O
nosocomial	O
bloodstream	B-Organism_substance
infections	O
in	O
the	O
United	O
States	O
,	O
and	O
Cryptococcus	O
neoformans	O
,	O
the	O
commonest	O
cause	O
of	O
fungal	O
meningitis	O
worldwide	O
[	O
1	O
]	O
,	O
[	O
2	O
]	O
.	O

Whilst	O
Candida	O
albicans	O
remains	O
the	O
leading	O
pathogenic	O
yeast	O
,	O
infections	O
due	O
to	O
non	O
-	O
C	O
.	O
albicans	O
species	O
such	O
as	O
Candida	O
glabrata	O
,	O
as	O
well	O
as	O
previously	O
rare	O
opportunists	O
such	O
as	O
Trichosporon	O
and	O
Geotrichum	O
species	O
,	O
are	O
increasingly	O
reported	O
[	O
1	O
]	O
,	O
[	O
3	O
]	O
-	O
[	O
6	O
]	O
.	O

Novel	O
pathogenic	O
Candida	O
species	O
such	O
as	O
Candida	O
nivariensis	O
and	O
Candida	O
bracarensis	O
have	O
also	O
been	O
described	O
[	O
7	O
]	O
.	O

Since	O
many	O
non	O
-	O
C	O
.	O
albicans	O
Candida	O
and	O
non	O
-	O
Candida	O
yeasts	O
are	O
resistant	O
or	O
less	O
susceptible	O
to	O
antifungal	O
agents	O
,	O
rapid	O
accurate	O
species	O
identification	O
is	O
central	O
to	O
timely	O
,	O
effective	O
antifungal	O
therapy	O
[	O
3	O
]	O
-	O
[	O
6	O
]	O
,	O
[	O
8	O
]	O
,	O
[	O
9	O
]	O
.	O

Conventional	O
phenotypic	O
-	O
based	O
methods	O
for	O
yeast	O
identification	O
,	O
however	O
,	O
are	O
slow	O
(	O
24	O
-	O
72	O
h	O
)	O
,	O
insensitive	O
and	O
often	O
unable	O
to	O
identify	O
more	O
unusual	O
species	O
.	O

Various	O
molecular	O
techniques	O
including	O
real	O
-	O
time	O
PCR	O
,	O
DNA	O
sequence	O
analysis	O
,	O
microarray	O
analysis	O
,	O
and	O
fluorescence	O
in	O
-	O
situ	O
hybridization	O
provide	O
accurate	O
identification	O
[	O
10	O
]	O
,	O
[	O
11	O
]	O
but	O
are	O
expensive	O
,	O
require	O
substantial	O
specimen	B-Cell
processing	O
time	O
(	O
hours	O
to	O
a	O
day	O
)	O
and	O
are	O
not	O
easily	O
implemented	O
as	O
routine	O
techniques	O
in	O
the	O
clinical	O
laboratory	O
.	O

Matrix	O
-	O
assisted	O
laser	O
desorption	O
ionization	O
-	O
time	O
of	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
)	O
has	O
emerged	O
as	O
a	O
powerful	O
and	O
rapid	O
tool	O
for	O
the	O
identification	O
of	O
bacterial	O
and	O
yeast	O
pathogens	O
[	O
12	O
]	O
-	O
[	O
17	O
]	O
.	O

Using	O
MALDI	O
-	O
TOF	O
MS	O
,	O
the	O
protein	O
spectral	O
"	O
fingerprint	O
"	O
of	O
an	O
isolate	O
is	O
compared	O
to	O
a	O
reference	O
spectral	O
database	O
for	O
identification	O
[	O
18	O
]	O
.	O

Previous	O
studies	O
have	O
reported	O
species	O
identification	O
rates	O
of	O
92	O
-	O
99	O
%	O
amongst	O
collections	O
of	O
yeasts	O
and	O
yeast	O
-	O
like	O
organisms	O
[	O
14	O
]	O
-	O
[	O
17	O
]	O
,	O
[	O
19	O
]	O
,	O
[	O
20	O
]	O
.	O

However	O
,	O
taken	O
collectively	O
,	O
the	O
results	O
may	O
not	O
be	O
directly	O
comparable	O
since	O
these	O
studies	O
have	O
used	O
different	O
approaches	O
to	O
assign	O
species	O
-	O
from	O
comparing	O
spectra	O
from	O
test	O
organisms	O
to	O
reference	O
spectra	O
in	O
MALDI	O
-	O
TOF	O
MS	O
databases	O
[	O
16	O
]	O
,	O
[	O
20	O
]	O
,	O
to	O
enhancing	O
these	O
databases	O
,	O
and	O
in	O
some	O
instances	O
developing	O
study	O
-	O
specific	O
databases	O
,	O
with	O
"	O
in	O
-	O
house	O
"	O
spectral	O
signatures	O
[	O
14	O
]	O
,	O
[	O
15	O
]	O
.	O

There	O
also	O
is	O
a	O
continuing	O
need	O
to	O
extend	O
the	O
repository	O
of	O
reference	O
spectra	O
in	O
MALDI	O
-	O
TOF	O
MS	O
databases	O
.	O

We	O
therefore	O
undertook	O
the	O
present	O
study	O
to	O
evaluate	O
the	O
utility	O
of	O
the	O
MALDI	O
Biotyper	O
2	O
.	O
0	O
Microflex	O
LT	O
spectrometer	O
(	O
Bruker	O
Daltonik	O
GmbH	O
;	O
Bremen	O
,	O
Germany	O
)	O
with	O
its	O
current	O
spectral	O
database	O
in	O
comparison	O
with	O
phenotypic	O
-	O
based	O
methods	O
for	O
the	O
identification	O
of	O
a	O
broad	O
range	O
of	O
yeasts	O
in	O
a	O
diagnostic	O
laboratory	O
.	O

The	O
first	O
part	O
of	O
the	O
study	O
comprised	O
testing	O
of	O
reference	O
and	O
clinical	O
strains	B-Cell
from	O
our	O
culture	O
collection	O
.	O

The	O
second	O
was	O
a	O
blinded	O
prospective	O
analysis	O
of	O
freshly	O
-	O
collected	O
yeast	O
isolates	O
recovered	O
during	O
routine	O
laboratory	O
work	O
flow	O
;	O
discrepant	O
results	O
between	O
MALDI	O
TOF	O
MS	O
and	O
phenotypic	O
methods	O
were	O
resolved	O
using	O
sequence	O
analysis	O
of	O
the	O
fungal	O
internal	O
transcribed	O
spacer	O
(	O
ITS	O
)	O
regions	O
[	O
21	O
]	O
,	O
[	O
22	O
]	O
.	O

Results	O
obtained	O
by	O
preparation	O
of	O
yeasts	O
by	O
extraction	O
of	O
fungal	O
proteins	O
and	O
by	O
direct	O
application	O
of	O
yeast	O
colonies	B-Cell
onto	O
the	O
MALDI	O
TOF	O
MS	O
plate	O
were	O
also	O
compared	O
.	O

